What payment methods are accepted?

We accept LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

What is the lead time for orders?

The average lead time is one month for both peak and off-peak seasons.

Veterinary Medicins Levamisole Hydrochloride Soluble Powder 20%

Name: Veterinary Medicins Levamisole Hydrochloride Soluble Powder 20%
Brand: Henan Muxiang Biological Co., Ltd.
SKU: 1950337062

Henan, ChinaHenan Muxiang Biological Co., Ltd.

US$2.35-10.68

1 kg

Sample price:US$1.00/kg.Request sample

Product profile

Customization

Available

Varieties

Parasite Disease Prevention Medicine

Component

Chemical Synthetic Drugs

Model NO.

chemical soluble powder

Type

The First Class

Pharmacodynamic Influential Factors

Combined Medication

Storage Method

Moisture Proof

Veterinary Reg. No.

160221284

Transport Package

100g, 500g, 1kg, 10kg, 25kg.

Specification

1kg/bag

Trademark

MOOSUN

Origin

Zhengzhou, Henan Province

HS Code

3004909099

Production Capacity

1500 Tons/Year

Key features

Effective Nematode Control: Controls nematodes in mature and immature stages in gastro-intestinal tract and lungs for poultry and livestock.

Versatile Administration: Oral administration via drinking water for poultry; specific dosage advised by veterinarians for livestock.

Flexible Packaging Options: Available in 100g or 150g sachets to suit different usage scales.

Long Shelf Life: Guaranteed 2-year shelf life when stored tightly sealed in a cool, dry place away from light.

OEM and ODM Services: Manufacturer offers both OEM and ODM services with 20 R&D engineers and advanced facilities.

Global Market Reach: Exports to North America, South America, Europe, Asia, Africa, and Australia since 2016.

Established Manufacturer: Operating since 2004 with 360 employees and over 16,000 square meters of plant area.

Multiple Payment Terms: Accepts LC, T/T, D/P, PayPal, Western Union, and small-amount payments for flexible transactions.

Company profile

Henan Muxiang Biological Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2016-02-01 CertifiedNearest Port: Shanghai Port, Qingdao PortAverage Response Time: ≤10.86h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryHenan Muxiang Biological Co., Ltd. is a China-based limited-company factory established in 2004, with 360 employees and operations in veterinary pharmaceuticals and animal-health products. The supplier reports seven pharmaceutical production lines, eight vaccine production lines, first-class production and inspection equipment, GMP management, ISO9001:2015 certification, and ISO/CNAS laboratory certification. Its R&D resources include more than 40 core personnel, over 30 of whom hold doctoral or master's degrees, while 21–30 quality-control staff are reported. The company exports to multiple global regions, has self-operated import and export rights, and states a one-month order-fulfillment period in both peak and off-peak seasons. Evidence supports capabilities in certification, innovation, production, and international operations. However, the provided information does not sufficiently establish after-sales service performance, financial credibility, customization execution, or specific customer cases.

Supplier typeThe supplier is identified as a limited company and a factory in the manufacturing industry, with its operating location in Henan, China. This indicates a direct manufacturing entity rather than only a trading or intermediary business.

CertificationsThe supplier reports a systematic GMP management system, ISO/CNAS laboratory international certification, and an ISO9001:2015 certificate. These stated certifications and quality systems provide explicit evidence of formal quality-management capability.

R&D capabilityThe supplier reports more than 40 core R&D personnel, including over 30 doctors or master's degree graduates, 20 years of preparation-technology experience among R&D engineers, and advanced R&D platforms such as a National Enterprise Technology Center, National Postdoctoral Research Station, and Academician Workstation. It also reports improving herbal active-ingredient extraction by more than 30% versus a traditional process, supporting a strong stated innovation profile.

Production capacityThe supplier reports seven pharmaceutical production lines and eight vaccine production lines, first-class production and inspection equipment, six production lines in a separate operational data field, and one-month order fulfillment in both peak and off-peak seasons. Although the line-count figures are not fully consistent across the slices, the evidence clearly supports substantial pharmaceutical and vaccine manufacturing capability.